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PP1.
Primary Carotid Artery Stenting versus Carotid Artery Stenting for
Post- Restenosis: Early and Late Outcomes
Ali F AbuRahma1, Shadi Abu-Halimah1, Jessica Bensenhaver1, Aravinda
Nanjundappa1, Patrick A. Stone1, L. Scott Dean2, Tammi Keiffer2, Mary
Emmett2, Zachary AbuRahma1. 1Robert C. Byrd Health Sciences Center of
W. Va. University, Charleston, WV; 2Charleston Area Medical Center,
Charleston, WV
Objectives: Carotid artery stenting (CAS) has been advocated as an
alternative to carotid endarterectomy (CEA) in high-risk surgical pa-
tients, including restenosis after CEA. This is the first study to compare
early and late clinical outcomes for primary CAS versus CAS for post-
CEA restenosis.
Methods: This study analyzes 180 high-risk surgical patients: 68 had
primary CAS (Group A) and 112 had CAS for post-CEA restenosis (Group
B [redo]). Patients were followed prospectively and had duplex ultrasounds
at one month, and every six months thereafter.
Results: Demographic/clinical characteristics were comparable for
both groups. Mean follow-up was 25 months (range: 1-78). The technical
success rate was 100%. Perioperative stroke rates and combined stroke/
death/MI rates were 7.4% for Group A versus 0.9% for Group B
(p0.0294). There was no perioperative MI, with one death secondary to
stroke. The combined early and late stroke rates for Groups A and B were
10.8% and 1.8%, respectively (p0.0275). Stroke-free rates at 1, 2, 3, and 4
years for Groups A and Bwere 89%, 89%, 89%, and 89%; and 98%, 98%, 98%,
and 98%, respectively (p0.0105, Figure 1). Two patients (3%) in Group A
and seven patients (6%) in Group B had 80% in-stent restenosis (all were
asymptomatic except one). Freedom from 80% in-stent restenosis at 1, 2,
3, and 4 years for Groups A and B were 100%, 98%, 98%, and 78%, versus
99%, 96%, 92%, and 87%, respectively (p0.7005). Freedom from target
vessel revascularization rates at 1, 2, 3, and 4 years for Groups A and B were
100%, 100%, 100%, and 100% versus 99%, 97%, 97%, and 92%, respectively
(p0.261).
Conclusions: CAS for CEA restenosis was safer than primary CAS,
however both had similar in-stent restenosis rates.
Author Disclosures: A.F. AbuRahma, None; S. Abu-Halimah, None; J.
Bensenhaver, None; A. Nanjundappa, None; P.A. Stone, None; L.S.
Dean, None; T. Keiffer, None; M. Emmett, None; Z. AbuRahma, None.
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Patient Cooperation During General Anesthesia for Carotid Endarter-
ectomy. A Third Anesthetic Option
Carlo Pratesi1, Sergio Bevilacqua2, Stefano Romagnoli2, Francesco Ciappi2,
walter dorigo1, Giovanni Pratesi3, John Marek4, Raffaele Pulli1. 1University
of Florence, florence, Italy; 2Careggi Hospital, florence, Italy; 3University of
Tor Vergata, Rome, Italy; 4University of New Mexico, Albuquerque, NM
Objectives: Carotid endarterectomy (CEA) is typically carried out
under either regional or general anesthesia. In the present study we analyze
a recently developed technique of Cooperative Patient General Anesthesia
(Co.Pa.Ge.A.) comparing it with the two conventional techniques of anes-
thesia.
Methods: 943 consecutive adult patients scheduled for carotid endar-
terectomy during the last 3 years were prospectively enrolled in a nonran-
domized trial comparing general, loco-regional and Co.Pa.Ge.A anesthetic
techniques. Co.Pa.Ge.A. is a general anesthetic technique based on the use
of a remifentanil infusion to allow patient cooperation and neurological
monitoring during general anesthesia without patient discomfort or anxiety.
Standard general anesthesia was performed in 132 patients (Group 1),
loco-regional anesthesia in 360 patients (Group 2), and Co.Pa.Ge.A. was
achieved in 451 cases (Group 3). The thirty-day rates of stroke, death and
cardiac outcomes were analyzed and comparison between the three groups
was performed with 
2 test.
Results: No difference was observed in mean patient age or gender
between groups. Preoperative neurologic symptoms were present in 237
(25.1%) of patients and 47 (5%) had a contralateral carotid occlusion with no
difference between the 3 groups. Co.Pa.Ge.A. was successful in 97.6% of
patients requiring conversion to standard general anesthesia in 2.4% because
of patient anxiety or temporary neurologic events. Intraoperative stroke
occurred in 2 patients (1.5%) in group 1 and in none in the other two groups.
Temporary carotid shunts were placed in 39 patients (29.5%) in group 1, 50
(13.9%) group 2 and 68 (15.1%) in group 3 (p0.001). Fatal and non-fatal
myocardial infarction occurred in the early postoperative period in one
patient (0.8%) in group 1, in 5 patients (1.4%) in group 2 and 4 patients
(0.9%) in group 3, without significant differences. The overall incidence of
stroke and death at 30 days from surgery, was 3.8% (5 patients) in group 1
and 0.8% (3 patients) in group 2, whereas no stroke or death was recorded in
group 3 (p0.001 for group 1 vs. groups 2 and 3).
Conclusions: Cooperative patient general anesthesia is a feasible and
safe alternative to standard general and local techniques for CEA with a
decreased incidence of stroke and death in the perioperative period.
Author Disclosures: C. Pratesi, None; S. Bevilacqua, None; S. Romag-
noli, None; F. Ciappi, None; W. dorigo, None; G. Pratesi, None; J.
Marek, None; R. Pulli, None.
PP3.
Longer Time Interval Between Carotid Cross Clamping and Shunting
is Associated with Increased 30-day Stroke/death Rate
Peter Paul Wisman1, Selma Tromp1, Rudolf Tutein Noltenius2, Frans L
Mol1, Hans Kelder1, Jean-Paul P. M. de Vries1. 1St Antonius, Nieuwegein,
Netherlands; 2Albert Schweitzer, Dordrecht, Netherlands
Objective: The benefit of carotid endarterectomy (CEA) in patients
with an (a)symptomatic 70% stenosis has been proven thoroughly. How-
ever, 30-day stroke/death rate after CEA is still 1-8%. We evaluated the
possible association between the time it took from carotid cross clamping to
uninterrupted flow through a carotid shunt (clamp-to-shunt time) and
30-day stroke/death rate in shunt-dependent patients.
Methods: From Jan. 2002 to July 2008 851 patients underwent CEA.
Patients were shunted selectively when, after clamping the carotid artery,
transcranial Doppler (TCD) showed a decrease of 70% of the flow in the
ipsilateral middle cerebral artery or when the electroencephalogram (EEG)
showed asymmetry or diffuse slowing. Both TCD and EEG were evaluated
on-line by a clinical neurophysiologist. All CEAs were performed by expe-
rienced vascular surgeons. In the study period 188/851 patients were
shunted and their electronic medical files were examined retrospectively.
The remaining shunted patients were divided into three groups according to
the clamp-to-shunt time; group 1, clamp-to-shunt time between 1-3 min;
group 2, 4-6 min and group 3, 7 min or longer. Primary endpoint was the
30-day stroke/death ratio.
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and another 3 patients lacked data concerning clamp-to-shunt time. There
were no significant differences between the three groups in the following
characteristics: sex, age, co-morbidity, patch/no-patch and symptomatic/
asymptomatic patients (t-tests). 30-day stroke/death rate increased with
longer clamp-to-shunt time: 3,6%, 5,6% and 12,8% in group 1 (n28), 2
(n89), and 3 (n39), respectively. We analyzed this effect using a binary
logistic regression model and found a two-tailed p-value of 0,093. The
confounding effect of peri-operative microembolic signals and intracranial
flow decrease measured by TCD at 1 and 3 minutes after carotid cross
clamping was controlled for.
Conclusions: Longer carotid-clamp-to-shunt time tends to increase
30 day stroke/death rate post-CEA in our selective shunting protocol.
When clamp-to-shunt time exceeded 7 minutes, more than 1 out of 8
patients ended with stroke or death. Again, time is brain!
Author Disclosures: P. Wisman, None; S. Tromp, None; R. Tutein
Noltenius, None; F.L. Mol, None; H. Kelder, None; J.P.M. de Vries,
None.
PP4.
Routine Carotid Endarterectomy Without a Shunt Even in the Pres-
ence Of a Contralateral Occlusion: A Review of 2027 Procedures
Russell H Samson, David P Showalter, Michael R Lepore, Jr., Deepak G
Nair. Florida State University Medical School, Sarasota, FL
Objectives: A 20 year prospective experience with routine non-shunt-
ing during carotid endarterectomy (CEA), even in the presence of a con-
tralateral internal carotid artery occlusion, is reviewed.
Method: Carotid endarterectomy was performed under general anes-
thesiawithout a shunt in 2027 consecutive CEA procedures in1780 patients:
733 procedures were performed on females and 1294 on males with ages
ranging from 37 to 97 years and a mean age of 73 years. Monitoring of
cerebral blood flow and/or function was not utilized in any patient. Blood
pressure was maintained above 130mmHg pharmacologically. Heparin
(7500U) and protamine reversal were uniformly used.
Results: A contralateral occlusion was present in 127 CEAs. 1344
CEAs were performed with a Dacron patch. Average cross clamp time was
18.5 minutes and 21 minutes for CEA without and with patches respec-
tively (minimum 8 minutes and maximum 58 minutes). Average cross
clamp time in the presence of a contralateral occlusion was 19.6 minutes.
Overall, neurological complications occurred within thirty days in 33
(1.62%) patients (17 strokes [0.84%] and 16 transient ischemic attacks
(TIAs) [0.79%]). There was only one stroke in a patient with a contralat-
eral occlusion (0.79%). Immediate postoperative events, i.e. those that
could be implicated as due to lack of a shunt, were rare (0.89%) (10
strokes [0.49%] and 8 TIAs, [0.39%]). There were 12 perioperative
deaths (0.59%) 4 following a stroke (0.2%) and 7 (0.35%) due a cardiac
event.
Conclusion:Carotid endarterectomymay be performed safely without
a shunt even in the presence of a contralateral occlusion. Further, contralat-
eral occlusion does not appear to add additional risk to CEA and should not
be considered a high risk for endarterectomy.
Author Disclosures: R.H. Samson, None; D.P. Showalter, None; M.R.
Lepore, None; D.G. Nair, None.
PP5.
Urgent Surgical Treatment of Carotid Stenosis in Patients with Acute
Neurologic Deficits
Michele Carmo, Giulio Mercandalli, Alberto M Settembrini, Patrizia Lat-
tuada, George Prouse, Andrea Rignano, Pietro Bassi, Piergiorgio G Settem-
brini. S.Carlo Borromeo Hospital - Milan, Milan, Italy
Objective: Late results from NASCET and ECST showed a greater
benefit for surgery if performed within 4 weeks from symptoms. Recent
studies have emphasized the risk of stroke after TIAs and of stroke recur-
rence after a first episode. Our aim is to describe our experience in treating
symptomatic carotid stenosis in an emergency setting.
Methods: All patients admitted for acute neurologic deficits to the
StrokeUnit from 1/2002 to 9/2008were considered possible candidates to
surgery. Those treated within 36 hrs from positive carotid imaging studies
were reviewed. All patients received a brain CT and an ABCD2 or NIHSS
score, as appropriate. Surgery was not offered if NIHSS  22. TIA was
defined by deficits lasting  24 hrs and negative CT for 72 hrs. Stroke wasdefined by symptoms lasting  24 hrs or positive CT. Neurologic compli-
cations were defined by a worsening NIHSS or new area of brain ischemia at
CT. End points were perioperative death / neurological morbidity as per
NIHSS.
Results: Among 55 patients (40 male, mean age 699.8 yrs), 17
were admitted for TIA (3 amaurosis, 8 single TIA, 6 recurrent) with a
mean ABCD2 score of 3.21.6 at admission; 38 had a stroke (34 minor,
4 stroke in evolution), with a median NIHSS of 3 (IQR 2-7.5); 14 of
them had a positive CT. Median time from symptoms to observation was
4 hrs (2-7), from observation to surgery 34 hrs (9-115), with no
difference between TIAs and strokes. We performed 54 endarterectomies
(37 patch, 14 direct, 3 eversion) and 1 embolectomy. Local or regional
anesthesia was used in 20 patients and general in 35. Among TIAs 1
patient died of an MI and 2 patients suffered a TIA postoperatively. In
the stroke group 1 patient died of a cerebral hemorrhage arisen on 4th
postop day, being symptoms free until then. 2 patients had a TIA (1 arm
weakness and 1 amaurosis). 3 patients experienced a worsening NIHSS:
2 had a stroke while the third had a hyperperfusion syndrome (all CTs
negative during hospital stay). Median NIHSS at discharge was 2 (1-3).
Overall the death/stroke rate was 5.9% for TIA patients and 10.5% for
stroke.
Conclusions: Early surgery had higher perioperative mortality and
stroke rates than expected. This can probably be acceptable for TIAs if
compared to their risk of stroke. Stroke patients most likely need a better
selection in order to pick up those who can benefit from early treatment.
Author Disclosures: M. Carmo, None; G. Mercandalli, None; A.M.
Settembrini, None; P. Lattuada, None; G. Prouse, None; A. Rignano,
None; P. Bassi, None; P.G. Settembrini, None.
PP6.
Effectiveness of Pharmacologic Risk Modification in the Prevention of
Symptom Development in Patients with Asymptomatic Carotid Artery
Occlusive Disease
Panagiotis Kougias, Joanna Forbes, Tam T. Huynh, Carlos F. Bechara,
Catherine Cagiannos, Peter H Lin. Baylor College of Medicine, Houston,
TX
Objectives: Patients with carotid artery occlusive disease (CAOD) are
often not offered intervention under the notion that aggressive medical
management might reduce their risk of stroke. This study was undertaken to
investigate the effectiveness of multiagent treatment with antiplatelets,
statins, beta blockers, and angiotensin converting enzyme inhibitors (ACE
I) in the prevention of neurologic complications in patients with asymptom-
atic 60-79% internal carotid artery (ICA) stenosis.
Methods: Using a case-control design the medical regimen of 176
patients with 60-79% ICA stenosis who developed symptoms of stroke or
transient ischemic attack (TIA) was compared to that of 218 asymptomatic
patients with similar ICA stenosis range. Odds ratio (OR) and 95% confi-
dence intervals (CI) were calculated for each of the variables of interest,
whereas level of significance was determined with Fisher’s exact test. A
logistic regression equation that utilized interaction expansion variables was
modeled to assess combined effects of individual medication classes on the
development of neurologic symptoms.
Results: Both groups were matched for age, gender, range of
stenosis in the diseased carotid artery and the occurrence of hypertension,
hyperlipidemia, diabetes, coronary artery disease, smoking, and chronic
obstructive pulmonary disease. Cases were more likely to have a history of
stroke than the controls (OR: 2.07, CI: 1.17-3.68, p0.007). The odds
of developing either stroke or TIA was not affected by the use of
antiplatelets (OR: 1.4, CI: 0.85-1.93, p0.09), statins (OR: 1.02, CI:
0.66-1.58, p0.9), ACE I (OR: 0.82, CI: 0.54-1.25, p0.34), or beta
blockers (OR: 0.96, CI: 0.63-1.46, p0.85). The lack of correlation
persisted after adjustment for possible counfounding effect among the
different medication classes. The interaction logistic regression model
demonstrated that only the combination of antiplatelet with beta block-
ers decrease the odds for occurrence of symptoms (OR: 0.34, CI:
0.14-0.78, p0.011).
Conclusion: Multiagent pharmacotherapy does not provide a defini-
tive neurologic risk reduction in patients with moderate asymptomatic
carotid stenosis. Larger prospective studies are necessary to address the role
of pharmacotherapy in neurologic complication prevention among patients
with CAOD.Author Disclosures: P. Kougias, None; J. Forbes, None; T.T. Huynh,
None; C.F. Bechara, None; C. Cagiannos, None; P.H. Lin, None.
